Evan Cromwell,
President & CEO
Dr. Cromwell is a successful entrepreneur and an innovative leader of instrument and assay product development teams. He has 30 years of senior executive and technical experience in research, engineering, bioassay development, production, and marketing. Prior to founding Protein Fluidics, he served as Director of Research at Molecular Devices and was a leader of a cross-OpCo scientific team for the Danaher Life Sciences group. He was Founder and President of Blueshift Biotechnologies, a high-content screening and analysis venture that was acquired by Molecular Devices in 2008. His passion is integrating new technologies into products that provide unexpected value to customers in life sciences and other communities. He holds a B.S. in Chemistry from Caltech and earned his Ph.D. in Physical Chemistry at the University of California, Berkeley. He has authored 40+ publications in the fields of biology, physical chemistry, and optical instrumentation and holds 16 patents.
|
|
|
